Jessica S. Beaver

A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia

Jeffrey A. Lieberman, G. C. Dunbar, Anthony C. Segreti et al. · Neuropsychopharmacology · 2012 · 175 citations

Medicine, Neuroscience, Pharmacology +15

Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia

David P. Walling, Stephen R. Marder, John M. Kane et al. · Schizophrenia Bulletin · 2015 · 97 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: Results of a randomized, double-blind, placebo-controlled trial*

Jean‐Louis Vincent, Herbert Spapen, Jacques Créteur et al. · Critical Care Medicine · 2006 · 40 citations

Nursing, Pharmacokinetics, Pharmacology +13

Pharmacokinetic and Pharmacodynamic Profiles of Extended Dosing of Epoetin Alfa in Anemic Patients Who Have Chronic Kidney Disease and Are Not on Dialysis

Tracy McGowan, Nicole Vaccaro, Jessica S. Beaver et al. · Clinical Journal of the American Society of Nephrology · 2008 · 31 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +8

Pharmacokinetics and pharmacodynamics of six epoetin alfa dosing regimens in anemic critically ill patients without acute blood loss*

Alejandro C. Arroliga, Kalpatha Guntupalli, Jessica S. Beaver et al. · Critical Care Medicine · 2009 · 25 citations

Medicine, Hematology, Pharmacology +14